$4.04
0.061.51%
近くで: Nov 16, 4:00 PM EST
$4.10
0.061.49%
時間外: 6:11 PM EST

The average analyst price target for Opus Genetics is $12.44, 203.4% above the current price. Of 16 analysts, 16 rate it Buy. Targets range from $5 to $20. The latest change came on Nov 11, 2026, when RBC Capital raised its price target on Opus Genetics from $9 to $11 and kept an Outperform rating.
Price Target Range — 8 Quarters
Analyst Consensus — 16 Analysts
Rating Trend — Last 9 Months